Hennessy Advisors Inc Bristol Myers Squibb CO Transaction History

Hennessy Advisors Inc

$2.81 Billion
Q3 2025

A detailed history of Hennessy Advisors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Hennessy Advisors Inc holds 95,700 shares of BMY stock, worth $4.26 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

95,700

Previous 97,200 1.54%

Holding current value

$4.26 Million

Previous $4.5 Million 4.07%

% of portfolio

0.15%

Previous 0.15%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$43.31 - $48.98 $64,965 - $73,470	-1,500 Reduced 1.54%	95,700 $4.32 Million
Q1 2025 Apr 16, 2025	SELL	$53.9 - $63.11 $59,290 - $69,421	-1,100 Reduced 1.12%	97,200 $5.93 Million
Q4 2024 Jan 14, 2025	SELL	$51.92 - $59.94 $186,912 - $215,784	-3,600 Reduced 3.53%	98,300 $5.56 Million
Q2 2024 Jul 23, 2024	SELL	$40.25 - $52.99 $84,525 - $111,279	-2,100 Reduced 2.02%	101,900 $4.23 Million
Q1 2024 Apr 15, 2024	BUY	$47.98 - $54.4 $4.99 Million - $5.66 Million	104,000 New	104,000 $5.64 Million
Q4 2023 Jan 18, 2024	SELL	$48.48 - $57.85 $198,768 - $237,185	-4,100 Reduced 5.43%	71,400 $3.66 Million
Q3 2023 Oct 18, 2023	SELL	$57.89 - $64.73 $92,624 - $103,568	-1,600 Reduced 2.08%	75,500 $4.38 Million
Q2 2023 Jul 17, 2023	SELL	$63.71 - $70.74 $273,953 - $304,182	-4,300 Reduced 5.28%	77,100 $4.93 Million
Q1 2023 Apr 14, 2023	SELL	$65.71 - $74.53 $105,135 - $119,248	-1,600 Reduced 1.93%	81,400 $5.64 Million
Q4 2022 Jan 20, 2023	SELL	$68.48 - $81.09 $102,720 - $121,635	-1,500 Reduced 1.78%	83,000 $5.97 Million
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $117 - $69,156	900 Added 1.08%	84,500 $6.01 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $670,132 - $803,548	10,900 Added 14.99%	83,600 $6.11 Million
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $85,808 - $100,032	-1,600 Reduced 2.15%	72,700 $4.53 Million
Q3 2021 Oct 12, 2021	SELL	$59.17 - $69.31 $71,004 - $83,172	-1,200 Reduced 1.59%	74,300 $4.4 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $326,370 - $367,070	5,500 Added 7.86%	75,500 $4.77 Million
Q4 2020 Jan 25, 2021	SELL	$57.74 - $65.43 $236,734 - $268,263	-4,100 Reduced 5.53%	70,000 $4.34 Million
Q3 2020 Oct 16, 2020	SELL	$57.43 - $63.64 $97,631 - $108,188	-1,700 Reduced 2.24%	74,100 $4.47 Million
Q2 2020 Jul 20, 2020	SELL	$54.82 - $64.09 $76,748 - $89,726	-1,400 Reduced 1.81%	75,800 $4.46 Million
Q1 2020 Apr 14, 2020	SELL	$46.4 - $67.43 $821,280 - $1.19 Million	-17,700 Reduced 18.65%	77,200 $4.3 Million
Q4 2019 Jan 14, 2020	SELL	$49.21 - $64.19 $216,524 - $282,436	-4,400 Reduced 4.43%	94,900 $6.09 Million
Q3 2019 Oct 07, 2019	SELL	$42.77 - $50.71 $115,479 - $136,917	-2,700 Reduced 2.65%	99,300 $5.04 Million
Q1 2019 Apr 08, 2019	BUY	$45.12 - $53.8 $550,464 - $656,360	12,200 Added 13.59%	102,000 $4.87 Million
Q4 2018 Jan 14, 2019	SELL	$48.76 - $63.23 $156,032 - $202,336	-3,200 Reduced 3.44%	89,800 $4.67 Million
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $5.57 Million - $6.42 Million	93,000 New	93,000 $5.88 Million

Others Institutions Holding BMY

# of Institutions

2,666

Shares Held

1.64B

Call Options Held

22.4M

Put Options Held

25.4M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $94.7B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hennessy Advisors Inc with notifications on news.

Account

Hennessy Advisors Inc Bristol Myers Squibb CO Transaction History